| 000 | 01502 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517102405.0 | ||
| 264 | 0 | _c20180220 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1476-5497 | ||
| 024 | 7 |
_a10.1038/ijo.2016.67 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFujioka, K | |
| 245 | 0 | 0 |
_aThe relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. _h[electronic resource] |
| 260 |
_bInternational journal of obesity (2005) _c09 2016 |
||
| 300 |
_a1369-75 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Obesity Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBupropion _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNaltrexone _xtherapeutic use |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPlodkowski, R | |
| 700 | 1 | _aO'Neil, P M | |
| 700 | 1 | _aGilder, K | |
| 700 | 1 | _aWalsh, B | |
| 700 | 1 | _aGreenway, F L | |
| 773 | 0 |
_tInternational journal of obesity (2005) _gvol. 40 _gno. 9 _gp. 1369-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/ijo.2016.67 _zAvailable from publisher's website |
| 999 |
_c26147646 _d26147646 |
||